Nerve Blocks for Hip Osteoarthritis
(PENG Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which nerve block better manages pain after hip replacement surgery: the fascia iliaca nerve block or the pericapsular nerve block. Both methods target specific nerves to reduce pain in the hip area. The trial seeks participants planning to undergo hip replacement using the anterior (front) approach and who have not regularly used opioids (strong pain medications) before. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, allowing researchers to understand how it benefits more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must not be taking opioids regularly before joining. If you are on opioids, you may need to stop them to participate.
What is the safety track record for these treatments?
Research shows that both the fascia iliaca nerve block and the pericapsular nerve block are generally safe for managing pain after hip surgery.
For the fascia iliaca nerve block, studies have found it effectively reduces pain and the need for pain medication like morphine after surgery. Patients using this block experienced less pain and required fewer pain-relieving drugs soon after their operation.
Regarding the pericapsular nerve block, research suggests it also effectively reduces pain and decreases the use of pain medications after surgery. This block targets specific nerves near the hip, aiding in pain management and improving recovery.
Both treatments have been tested in previous studies and have shown positive results in terms of safety and effectiveness. They are generally well-tolerated, with no major safety concerns reported in the available research.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about nerve blocks for hip osteoarthritis because they offer a unique approach compared to traditional pain management options like oral medications or injections. Fascia Iliaca Nerve Block specifically targets the space between the iliacus muscle and fascia, directly affecting the femoral and lateral femoral cutaneous nerves. Meanwhile, the Pericapsular Nerve Block focuses on the anterior hip capsule, blocking the articular branches of the femoral and accessory obturator nerves. These targeted techniques aim to provide more precise pain relief, potentially reducing side effects associated with systemic treatments. This precision in targeting could mean faster and more effective relief for patients suffering from hip osteoarthritis.
What evidence suggests that this trial's nerve block treatments could be effective for hip osteoarthritis?
This trial will compare the effectiveness of two nerve block treatments for hip osteoarthritis: the Fascia Iliaca Nerve Block and the Pericapsular Nerve Block. Studies have shown that fascia iliaca nerve blocks effectively reduce pain and the need for opioids after hip surgeries, providing good pain relief for up to 24 hours. Research indicates that patients using fascia iliaca blocks often require less morphine and experience shorter hospital stays.
The pericapsular nerve block also lowers pain and opioid use, improving hip function after surgery. Some studies suggest that this block reduces pain for up to two months in hip osteoarthritis patients. Both treatments have shown promise in managing hip pain, making them valuable options for pain control after hip surgery. Participants in this trial will receive one of these nerve block treatments to evaluate their effectiveness in managing hip pain.23678Who Is on the Research Team?
Ronald Delanois, MD
Principal Investigator
LifeBridge Health
Are You a Good Fit for This Trial?
This trial is for adults planning to undergo primary total hip arthroplasty using the anterior approach, with an ASA score of 1-3, and who have not been taking opioids. They must be willing to follow study procedures and provide consent. Excluded are those with general anesthesia during surgery, certain conditions like ankylosing spondylitis or chronic pain, opioid tolerance, or allergies to medications used in the nerve blocks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Scheduled pre-operative visit for preparation and baseline assessments
Operative
Participants undergo total hip arthroplasty with assigned nerve block regimen
Post-operative
Participants receive postoperative care and pain management, including monitoring of opioid consumption
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 2-week and 4-6 week intervals
What Are the Treatments Tested in This Trial?
Interventions
- Fascia Iliaca Nerve Block
- Pericapsular Nerve Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
LifeBridge Health
Lead Sponsor
Rubin Institute for Advanced Orthopedics
Collaborator